Literature DB >> 9566759

Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope.

I Dalum1, M R Jensen, K Gregorius, C M Thomasen, H I Elsner, S Mouritsen.   

Abstract

Self proteins are handled in the same way as foreign proteins by antigen presenting cells, but because of T-cell tolerance the presentation of self peptides does not normally lead to T cell activation. By providing physically linked T-cell help it is possible to overcome the B cell non-responsiveness toward self antigens. We have shown previously that a very potent antibody response, cross-reactive with a self protein, can be rapidly induced by immunizing with a recombinant immunogen consisting of the self protein with a foreign immunodominant T helper epitope inserted into its sequence (Dalum, I., Jensen, M. R., Hindersson, P., Elsner, H. I. and Mouritsen, S. (1996) J. Immnunol. 157, 4796). In this study we compare this approach for inducing autoantibodies against a self protein with the traditional method of conjugating the self antigen to a foreign carrier protein. The highly conserved self protein ubiquitin with an inserted epitope from ovalbumin (UbiOVA) is used as a model protein and compared to two traditionally conjugated immunogens consisting of ubiquitin chemically conjugated to a peptidic T helper epitope or to ovalbumin. The traditionally conjugated immunogens induce much slower and low titered ubiquitin specific antibody responses than the recombinant construct which also is capable of inducing antibodies directed against a much broader range of potential ubiquitin B cell determinants than the chemically conjugated immunogens. All three constructs are processed by antigen presenting cells and ovalbumin derived T cell epitopes are presented to T helper cells. From these observations it seems likely that the presence of non-shielded autologous B cell determinants on the immunogen is critical for the ability to induce a strong autoantibody response with a diverse fine specificity. Furthermore, the ubiquitin specific antibodies induced by UbiOVA contain higher levels of IgG2a/b relative to IgG1 compared to the conjugates. We therefore speculate that the insertion of a T cell epitope directly into the self antigen could possibly induce an immune response with a different Th1/Th2 balance than a response induced with traditional conjugates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9566759     DOI: 10.1016/s0161-5890(97)00147-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.

Authors:  M Richard; R K Grencis; N E Humphreys; J C Renauld; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis.

Authors:  T Ohkawara; Y Koyama; S Onodera; H Takeda; M Kato; M Asaka; J Nishihira
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

3.  The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Authors:  Sami El Khatib; Mohamed Salla
Journal:  Leuk Res Rep       Date:  2022-06-27

4.  Recombinatorial cloning using heterologous lox sites.

Authors:  Robert W Siegel; Nileena Velappan; Peter Pavlik; Leslie Chasteen; Andrew Bradbury
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

5.  Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis.

Authors:  Guo-dong Feng; Xiao-chang Xue; Mei-li Gao; Xian-feng Wang; Zhen Shu; Nan Mu; Yuan Gao; Zeng-lu Wang; Qiang Hao; Wei-na Li; Meng Li; Cun Zhang; Wei Zhang; Ying-qi Zhang
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

6.  Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine.

Authors:  Nan Mu; Nannan Liu; Qiang Hao; Yujin Xu; Jialin Li; Weina Li; Shouzhen Wu; Cun Zhang; Haichuan Su
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

7.  Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.

Authors:  Liliane Goetsch; Jean Francois Haeuw; Thierry Champion; Christine Lacheny; Thien N'Guyen; Alain Beck; Nathalie Corvaia
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

8.  TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model.

Authors:  A M Waterston; F Salway; E Andreakos; D M Butler; M Feldmann; R C Coombes
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

9.  A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis.

Authors:  Changzhen Liu; Yunfeng Zhao; Wen He; Wei Wang; Yuan Chen; Shiqian Zhang; Yijing Ma; Jin Gohda; Takaomi Ishida; Thomas S Walter; Raymond J Owens; David I Stuart; Jingshan Ren; Bin Gao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Lack of patent liver autoimmunity after breakage of tolerance in a mouse model.

Authors:  Giovanna Del Pozzo; Dina Mascolo; Antonella Prisco; Pasquale Barba; Annamaria Anzisi; John Guardiola
Journal:  Int Immunol       Date:  2003-10       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.